| 南台科技大學 |
2002 |
(Pd+Pt)奈米結構電極的製備與催化活性分析
|
賴龍標 |
| 臺大學術典藏 |
2022-09-15T01:08:53Z |
PD-1 blockade in anaplastic thyroid carcinoma
|
Capdevila J.; Wirth L.J.; Ernst T.; Aix S.P.; Chia-Chi Lin; Ramlau R.; Butler M.O.; Delord J.-P.; Gelderblom H.; Ascierto P.A.; Fasolo A.; F?hrer D.; H?tter-Kr?nke M.L.; Forde P.M.; Wrona A.; Santoro A.; Sadow P.M.; Szpakowski S.; Wu H.; Bostel G.; Faris J.; Cameron S.; Varga A.; Taylor M. |
| 國立臺灣大學 |
2012 |
PD-1 Blockage Reverses Immune Dysfunction and Hepatitis B Viral Persistence in a Mouse Animal Model
|
Tzeng, Horng-Tay; Tsai, Hwei-Fang; Liao, Hsiu-Jung; Lin, Yi-Jiun; Chen, Lieping; Chen, Pei-Jer; Hsu, Ping-Ning; 陳培哲; 許秉寧 |
| 國立臺灣大學 |
2012 |
PD-1 blockage reverses immune dysfunction and hepatitis B viral persistence in a mouse animal model
|
Tzeng, HorngTay; Chen, PeiJer; Hsu, PingNing; 陳培哲; 許秉寧 |
| 臺大學術典藏 |
2021-02-02T02:48:04Z |
PD-1 blockage reverses immune dysfunction and hepatitis B viral persistence in a mouse animal model
|
Tzeng H.-T.; Tsai H.-F.; Liao H.-J.; Lin Y.-J.; Chen L.; Chen P.-J.; PING-NING HSU |
| 臺大學術典藏 |
2021-07-03T03:34:26Z |
PD-1 blockage reverses immune dysfunction and hepatitis B viral persistence in a mouse animal model
|
Tzeng H.-T.; Tsai H.-F.; Liao H.-J.; Lin Y.-J.; Chen L.; PEI-JER CHEN; Hsu P.-N. |
| 高雄醫學大學 |
2009 |
Pd-Ag合金不同世代反覆鑄造之探討
|
洪純正;葉津孜;賴珮翎;蔡菁芳;陳文正 |
| 國立臺灣大學 |
2009-09 |
Pd-C-Fe Nanoparticles Investigated by X-ray Absorption Spectroscopy as Electrocatalysts for Oxygen Reduction
|
Yeh, Yun-Chieh; Chen, Hao Ming; Liu, Ru-Shi; Asakura, Kiyotaka; Lo, Man-Yin; Peng, Yu-Min; Chan, Ting-Shan; Lee, Jyh-Fu |
| 國立臺灣科技大學 |
2012 |
Pd-catalysed direct arylation polymerisation for synthesis of low-bandgap conjugated polymers and photovoltaic performance
|
Chang, S.-W.;Waters, H.;Kettle, J.;Kuo, Z.-R.;Li, C.-H.;Yu, C.-Y.;Horie, M. |
| 臺大學術典藏 |
2020-01-06T03:08:59Z |
Pd-catalyzed growth of Pt nanoparticles or nanowires as dense coatings on polymeric and ceramic particulate supports
|
Lee, Eric P.; Chen, Jingyi; Yin, Yadong; Campbell, Charles T.; Xia, Younan; KEH-CHYANG(ERIC) LEE |
| 國立交通大學 |
2020-10-05T02:02:03Z |
Pd-Catalyzed Redox-Neutral C-N Coupling Reaction of Iminoquinones with Electron-Deficient Alkenes without External Oxidants: Access of Tertiary (E)-Enamines and Application to the Synthesis of Indoles and Quinolin-4-ones
|
Jillella, Raveendra; Raju, Selvam; Hsiao, Huan-Chang; Hsu, Day-Shin; Chuang, Shih-Ching |
| 國立成功大學 |
2025-06-24 |
PD-FEM耦合方法應用於混合維度模型之疲勞裂紋擴展分析
|
周紘任; Chou, Hung-Jen |
| 國立交通大學 |
2014-12-08T15:04:03Z |
PD-GE CONTACT TO N-GAAS WITH THE TIW DIFFUSION BARRIER
|
HUANG, WC; LEI, TF; LEE, CL |
| 元智大學 |
2011-10 |
Pd-integrated lanthanum-transition metal perovskites for methanol partial oxidation
|
Chia-Liang Li; Chien-Lin Wang; Yu-Chuan Lin |
| 嘉南藥理大學 |
2022 |
PD-L1 expressed from tumor cells promotes tumor growth and invasion in lung cancer via modulating TGF-β1/SMAD4 expression
|
Chen, Ming-Jenn; Wang, Yao-Chen; Wang, Lee; Shen, Ching-Ju; Chen, Chih-Yi; Lee, Huei |
| 臺大學術典藏 |
2021-08-23T03:20:27Z |
PD-L1 expression and outcome in patients with metastatic non-small cell lung cancer and EGFR mutations receiving EGFR-TKI as frontline treatment
|
Chang C.-Y.; Lai Y.-C.; Wei Y.-F.; CHUNG-YU CHEN; Chang S.-C. |
| 國家衛生研究院 |
2022-10-31 |
PD-L1 expression in high-risk early-stage colorectal cancer-its clinical and biological significance in immune microenvironment
|
Chung, BS;Liao, IC;Lin, PC;Wu, SY;Kang, JW;Lin, BW;Chen, PC;Chan, RH;Lee, CT;Shen, MR;Chen, SH;Yeh, YM |
| 國立成功大學 |
2022-11 |
PD-L1 Expression in High-Risk Early-Stage Colorectal Cancer-Its Clinical and Biological Significance in Immune Microenvironment
|
Chung;Bing-Syuan;Liao;I-Chuang;Lin;Peng-Chan;Wu;Shang-Yin;Kang;Jui-Wen;Lin;Bo-Wen;Chen;Po-Chuan;Chan;Ren-Hao;Lee;Chung-Ta;Shen;Meng-Ru;Chen;Shang-Hung;Yeh;Yu-Min |
| 國立成功大學 |
2022-11 |
PD-L1 Expression in High-Risk Early-Stage Colorectal Cancer-Its Clinical and Biological Significance in Immune Microenvironment
|
葉裕民; YEH, YU-MIN; Chung, Bing-Syuan;Liao, I-Chuang;Lin, Peng-Chan;Wu, Shang-Yin;Kang, Jui-Wen;Lin, Bo-Wen;Chen, Po-Chuan;Chan, Ren-Hao;Lee, Chung-Ta;Shen, Meng-Ru;Chen, Shang-Hung;Yeh, Yu-Min |
| 國立成功大學 |
2022 |
PD-L1 Expression in High-Risk Early-Stage Colorectal Cancer—Its Clinical and Biological Significance in Immune Microenvironment
|
Chung, B.-S.;Liao, I.-C.;Lin, P.-C.;Wu, S.-Y.;Kang, J.-W.;Lin, B.-W.;Chen, P.-C.;Chan, R.-H.;Lee, C.-T.;Shen, M.-R.;Chen, S.-H.;Yeh, Yeh Y.-M. |
| 臺大學術典藏 |
2021-10-27T03:22:16Z |
PD-L1 expression in megakaryocytes and its clinicopathological features in primary myelofibrosis patients
|
Lee S.-H.; Lin C.-C.; Wei C.-H.; Chang K.-P.; CHANG-TSU YUAN; Tsai C.-H.; Liu J.-H.; Hou H.-A.; Tang J.-L.; Chou W.-C.; Tien H.-F. |
| 臺大學術典藏 |
2021-11-24T07:29:13Z |
PD-L1 expression in megakaryocytes and its clinicopathological features in primary myelofibrosis patients
|
Lee, Sze-Hwei; CHIEN-CHIN LIN; Wei, Chao-Hong; Chang, Ko-Ping; Yuan, Chang-Tsu; Tsai, Cheng-Hong; Liu, Jia-Hao; Hou, Hsin-An; Tang, Jih-Lu; Chou, Wen-Chien; Tien, Hwei-Fang |
| 臺大學術典藏 |
2022-01-10T08:56:43Z |
PD-L1 expression in megakaryocytes and its clinicopathological features in primary myelofibrosis patients
|
Lee, Sze-Hwei; Lin, Chien-Chin; Wei, Chao-Hong; Chang, Ko-Ping; Yuan, Chang-Tsu; CHENG-HONG TSAI; Liu, Jia-Hao; Hou, Hsin-An; Tang, Jih-Lu; Chou, Wen-Chien; Tien, Hwei-Fang |
| 臺大學術典藏 |
2022-01-10T08:05:31Z |
PD-L1 expression in megakaryocytes and its clinicopathological features in primary myelofibrosis patients
|
Lee, Sze-Hwei; Lin, Chien-Chin; Wei, Chao-Hong; Chang, Ko-Ping; Yuan, Chang-Tsu; Tsai, Cheng-Hong; Liu, Jia-Hao; Hou, Hsin-An; Tang, Jih-Lu; Chou, Wen-Chien; Tien, Hwei-Fang |
| 臺大學術典藏 |
2022-01-25T05:25:46Z |
PD-L1 expression in megakaryocytes and its clinicopathological features in primary myelofibrosis patients
|
Lee, Sze-Hwei; Lin, Chien-Chin; Wei, Chao-Hong; Chang, Ko-Ping; Yuan, Chang-Tsu; Tsai, Cheng-Hong; Liu, Jia-Hao; Hou, Hsin-An; Tang, Jih-Lu; Chou, Wen-Chien; HWEI-FANG TIEN |
| 臺大學術典藏 |
2021-09-14T23:18:36Z |
PD-L1 expression in megakaryocytes and its clinicopathological features in primary myelofibrosis patients
|
Lee, Sze Hwei; CHIEN-CHIN LIN; Wei, Chao Hong; Chang, Ko Ping; Yuan, Chang Tsu; CHENG-HONG TSAI; Liu, Jia Hao; HSIN-AN HOU; Tang, Jih Lu; WEN-CHIEN CHOU; HWEI-FANG TIEN |
| 臺大學術典藏 |
2022-01-12T07:07:06Z |
PD-L1 expression in megakaryocytes and its clinicopathological features in primary myelofibrosis patients
|
Lee S.-H.; Lin C.-C.; Wei C.-H.; Chang K.-P.; Yuan C.-T.; Tsai C.-H.; Liu J.-H.; HSIN-AN HOU; Tang J.-L.; Chou W.-C.; Tien H.-F. |
| 臺大學術典藏 |
2022-04-26T08:31:15Z |
PD-L1 expression in megakaryocytes and its clinicopathological features in primary myelofibrosis patients
|
Lee, Sze-Hwei; Lin, Chien-Chin; Wei, Chao-Hong; Chang, Ko-Ping; Yuan, Chang-Tsu; Tsai, Cheng-Hong; Liu, Jia-Hao; Hou, Hsin-An; Tang, Jih-Lu; WEN-CHIEN CHOU; Tien, Hwei-Fang |
| 臺大學術典藏 |
2022-08-12T08:07:48Z |
PD-L1 expression in megakaryocytes and its clinicopathological features in primary myelofibrosis patients
|
Lee S.-H.; Lin C.-C.; Wei C.-H.; Chang K.-P.; CHANG-TSU YUAN; Tsai C.-H.; Liu J.-H.; Hou H.-A.; Tang J.-L.; Chou W.-C.; Tien H.-F. |
| 臺大學術典藏 |
2022-02-14T23:55:52Z |
PD-L1 Expression in Monocytes Correlates with Bacterial Burden and Treatment Outcomes in Active Pulmonary Tuberculosis
|
Pan, Sheng Wei; CHIN-CHUNG SHU; Huang, Jhong Ru; Lee, Chang Ching; Tseng, Yen Han; Hung, Jung Jyh; Hsu, Po Kuei; Chen, Nien Jung; Su, Wei Juin; Feng, Jia Yih; Chen, Yuh Min |
| 國立臺灣大學 |
2015 |
PD-L1 is highly expressed in lung lymphoepithelioma-like carcinoma: A potential rationale for immunotherapy
|
Chang, Yih-Leong; Yang, Ching-Yao; Lin, Mong-Wei; Wu, Chen-Tu; Yang, Pan-Chyr; 吳振都; 張逸良; 楊泮池; 楊景堯; 林孟暐 |
| 臺大學術典藏 |
2020-02-20T02:56:58Z |
PD-L1 is highly expressed in lung lymphoepithelioma-like carcinoma: A potential rationale for immunotherapy
|
Chang Y.-L.; CHING-YAO YANG; Lin M.-W.; Wu C.-T.; Yang P.-C. |
| 臺大學術典藏 |
2020-03-06T05:26:12Z |
PD-L1 is highly expressed in lung lymphoepithelioma-like carcinoma: A potential rationale for immunotherapy
|
YIH-LEONG CHANG; Yang C.-Y.; Lin M.-W.; Wu C.-T.; Yang P.-C. |
| 臺大學術典藏 |
2020-03-07T06:56:23Z |
PD-L1 is highly expressed in lung lymphoepithelioma-like carcinoma: A potential rationale for immunotherapy
|
Lin M.-W.; Wu C.-T.; Yang P.-C.; Yang C.-Y.; YIH-LEONG CHANG; Yih-Leong Chang;Yang C.-Y.;Lin M.-W.;Wu C.-T.;Yang P.-C. |
| 臺大學術典藏 |
2015 |
PD-L1 is highly expressed in lung lymphoepithelioma-like carcinoma: A potential rationale for immunotherapy
|
Lin M.-W.; Wu C.-T.; Yang P.-C.; CHING-YAO YANG; Chang Y.-L. |
| 臺大學術典藏 |
2020-12-02T02:33:30Z |
PD-L1 is highly expressed in lung lymphoepithelioma-like carcinoma: A potential rationale for immunotherapy
|
Chang Y.-L.; Yang C.-Y.; Lin M.-W.; Wu C.-T.; Pan-Chyr Yang; Chang Y.-L.; Yang C.-Y.; Lin M.-W.; Wu C.-T.; PAN-CHYR YANG |
| 臺大學術典藏 |
2021-10-08T08:16:31Z |
PD-L1 is highly expressed in lung lymphoepithelioma-like carcinoma: A potential rationale for immunotherapy
|
Chang Y.-L.; Yang C.-Y.; MONG-WEI LIN; Wu C.-T.; Yang P.-C. |
| 臺大學術典藏 |
2022-03-04T05:33:34Z |
PD-L1 is highly expressed in lung lymphoepithelioma-like carcinoma: A potential rationale for immunotherapy
|
Chang Y.-L.; Yang C.-Y.; Lin M.-W.; CHEN-TU WU; Yang P.-C. |
| 臺大學術典藏 |
2018-09-10T15:27:10Z |
PD-L1 is highly expressed in lung lymphoepithelioma-like carcinoma: A potential rationale for immunotherapy.
|
Chang, Yih-Leong;Yang, Ching-Yao;Lin, Mong-Wei;Wu, Chen-Tu;Yang, Pan-Chyr; Yih-Leong Chang, Ching-Yao Yang, Mong-Wei Lin, Chen-Tu Wu, Pan-Chyr Yang; 吳振都;張逸良;楊泮池;楊景堯;林孟暐; Chang, Yih-Leong; CHING-YAO YANG; CHEN-TU WU; Yang, Ching-Yao; Lin, Mong-Wei; YIH-LEONG CHANG; Wu, Chen-Tu; Yang, Pan-Chyr |
| 臺大學術典藏 |
2022-09-06T01:55:22Z |
PD-L1 strong expressions affect the clinical outcomes of osimertinib in treatment naïve advanced EGFR-mutant non-small cell lung cancer patients
|
Hsu, Kuo-Hsuan; Tseng, Jeng-Sen; Yang, Tsung-Ying; Chen, Kun-Chieh; Su, Kang-Yi; SUNG-LIANG YU; Chen, Jeremy J W; Huang, Yen-Hsiang; Chang, Gee-Chen |
| 國家衛生研究院 |
2020-11-03 |
PD-L1/PD-1 blockade in breast cancer: The immunotherapy era (Review)
|
Li, CJ;Lin, LT;Hou, MF;Chu, PY |
| 國立成功大學 |
2019 |
PD-L1不只是Biomarker！探討肺癌細胞本身的PD-L1促進轉移的機轉，及其與TIP60-mediated 癌症EMT的相關性
|
蘇文彬 |
| 國立成功大學 |
2018 |
PD-L1不只是Biomarker！探討肺癌細胞本身的PD-L1促進轉移的機轉，及其與TIP60-mediated 癌症EMT的相關性
|
蘇文彬 |
| 國家衛生研究院 |
2008 |
PD-L1在小鼠自體免疫性糖尿病動物模式之幹細胞治療所扮演的角色
|
顏伶汝;司徒惠康 |
| 國家衛生研究院 |
2010 |
PD-L1在小鼠自體免疫性糖尿病動物模式之幹細胞治療所扮演的角色
|
顏伶汝;司徒惠康 |
| 國家衛生研究院 |
2009 |
PD-L1在小鼠自體免疫性糖尿病動物模式之幹細胞治療所扮演的角色
|
顏伶汝;司徒惠康 |
| 國立成功大學 |
2016 |
PD-L1在肺癌的探索及其治療應用—與 mTOR inhibitor，DNA damage agents及DNA修補蛋白MORF 的相關性
|
蘇文彬 |
| 國立成功大學 |
2006-04 |
Pd-oxide-Al0.24Ga0.76As (MOS) high electron mobility transistor (HEMT)-based hydrogen sensor
|
Cheng, Chin-Chuan; Tsai, Yan-Ying; Lin, Kun-Wei; Chen, Huey-Ing; Hsu, Wei-Hsi; Hung, Ching-Wen; Liu, Rong-Chau; Liu, Wen-Chau |
| 國立交通大學 |
2017-04-21T06:49:36Z |
PD-SOI MOSFET Body-to-Body Leakage Scaling Trend and Optimization
|
Lo, H. C.; Luo, W. C.; Lu, W. Y.; Cheng, C. F.; Wu, Benny; Chen, T. L.; Lien, C. H.; Fung, Samuel K. H.; Tuan, H. C. |
| 大葉大學 |
2006-06 |
PD-Type Iterative Learning Control for Trajectory Tracking of Pneumatic X-Y Table with Disturbances
|
Chen, Chih-Keng;Hwang, James |
